Mesenteric lymph duct ligation improves survival in a lethal shock model

Shock

Volumn 30, Issue 6, 2008, Pages 680-685

  Badami, Chirag D ^a   Senthil, Maheswari ^a   Caputo, Francis J ^a   Rupani, Bobby J ^a   Doucet, Danielle ^a   Pisarenko, Vadim ^a   Xu, Da Zhong ^a   Lu, Qi ^a   Feinman, Rena ^a   Deitch, Edwin A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

iNOS; Irreversible shock; Lymph duct ligation; Mesenteric lymph; Splanchnic artery occlusion

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRATE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; EXPERIMENTAL LIGATION; HYPOTENSION; INTESTINE LYMPHATIC TISSUE; LETHALITY; LYMPH VESSEL; MALE; MESENTERIC DUCT; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SHOCK; SPRAGUE DAWLEY RAT; SURVIVAL; SYSTEMIC CIRCULATION;

ANIMALS; DISEASE MODELS, ANIMAL; GASTROINTESTINAL TRACT; LIGATION; LYMPHATIC VESSELS; MALE; NEUTROPHIL ACTIVATION; RATS; RATS, SPRAGUE-DAWLEY; SHOCK;

EID: 58149270907     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318173edd1     Document Type: Article

References (43)

1. Deitch EA: Multiple organ failure: pathophysiology and potential future therapy. Ann Surg 216:117-134. 1992.
2. Deitch EA. Sambol JT: The gut-origin hypothesis of MODS. In: Deitch EA. Vincent JL. Windsor A. eds.: Sepsis and Multiple Organ Dysfunction: A Multidisciplinary Approach. Philadelphia. PA: W.B. Saunders. 2002. pp 105 316.
3. Deitch EA. Xu DZ. Lu Q: Gut lymph hypothesis of early shock and traumainduced multiple organ dysfunction syndrome: a new look at gut origin sepsis. J Org Dys 2:70-79. 2006.
4. Squadrito F. Sturniolo R. Altavilla D. Santoro G. Campo GM. Arena A. Caputi AP: Platelet activating factor involvement in splanchnic artery occlusion shock in rats. Eur J Pharmacol 192:47-53, 1991.
5. Squadrito F. Altavilla D. Canale P. Ioculano M. Campo GM. Ammendolia L. Ferlito M. Zingarelli B. Squadrito G. Saitta A. et al.: Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock. Br J Pharmacol 113:1153-1158. 1994.
6. Cuzzocrea S, Chatterjee PK. Mazzon E. Dugo L. De Sarro A. Van de Loo FAJ. Caputi AP. Thiemermann C: Role of induced nitric oxide in the initiation of inflammatory response after post ischemic injury. Shock 18:169-176. 2002.
7. Suzuki Y, Deitch EA. Mishima S. Lu Q. Xu DZ: Inducible nitric oxide synthase gene knock out mice has increased resistance to gut injury and bacterial translocation after an intestinal ischemia-reperfusion injury. Crit Care Med 28:3692-3696. 2000.
8. Hoyt DB. Bulger EM. Knudson MM, Morris J. Ierardi R. Sugerman HJ. Shackford SR. Landercasper J. Winchell RJ. Jurkovich G. et al.: Death in the operating room, an analysis of a multi-center experience. J Trauma 37: 426-432. 1994.
9. Ferrara A. MacArthur JD. Wright HK. Modlin IM. McMillen MA: Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg 160:515-518. 1990.
10. Robin JK. Oliver JA. Landry DW: Vasopressin deficiency in the syndrome of irreversible shock. J Trauma 54:S149-SI54. 2003.
11. Thiemermann C. Szabo C. Mitchell JA. Vane JR: Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci U S A 90:267 271.1993.
12. Zingarelli B. Squadrito F. Altavilla D. Calapai G. Di Rosa M. Caputi AP: Role of tumor necrosis factor in acute hypovolemic hemorrhagic shock in rats. Am J Physiol 266:H15I2-H15I5. 1994.
13. Zingarelli B. Squadrito F. Ioculano M. Altavilla D. Bussolino F. Campo GM. Caputi AP: Platelet activating factor interaction with tumor necrosis factor and myocardial depressant factor in splanchnic artery occlusion shock. Eur J Pharm 222:13-19. 1992.
14. Yang G. Liu L. Xu J. Li T: Effect of arginine vasopressor on vascular reactivity and calcium sensitivity after hemorrhagic shock in rats and its relationship to Rho-kinase. J Trauma 61:1336-1342. 2006.
15. Schrier RW. Wang W: Mechanisms of disease: acute renal failure and sepsis. N Engl J Med 351:159-169. 2004.
16. Lillehei RC: The intestinal factor in irreversible hemorrhagic shock. Surgery 42:1043-1054. 1957.
17. Chang TW: Improvement of survival from hemorrhagic shock by enterectomy in rats: findings to implicate the role of the gut for irreversibility of hemorrhagic shock. J Trauma 42:223-230. 1957.
18. Squadrito F. Altavilla D. Squadrito G. Ferlito M. Deodato B. Arlolta M. Minutoli L. Campo GM. Bova A. Quartarone C. et al.: Protective effect of cyclosporine-A in splanchnic artery occlusion shock. Br J Pharmacol 130: 339-344. 2000.
19. Senthil M, Watkins A. Barbs D. Xu DZ. Lu Q. Abungu B. Caputo F. Feinman R. Deitch EA: Intravenous injection of trauma-hemorrhagic shock mesenteric lymph causes lung injury that is dependent upon activation of the inducible nitric oxide synthase pathway. Ann Surgery 246:822-830. 2(K)7.
20. Salzman AL: Nitric oxide in the gut. New Horiz 3:33-45. 1995.
21. Haglund U: The splanchnic organs as the source of toxic mediators in shock. Prog Clin Biol Res 264:135-145. 1988.
22. Mitsuoka H. Kistler EB. Schmid-Schonbein GW: Generation of in vivo activating factors in the ischemic intestine by pancreatic factors. Proc Natl Acad Sci U S A 97:1772-1777. 2000.
23. Kistler EB. Hugli TE. Schmid-Schobein GW: The pancreas as a source of cardiovascular cell activating factors. Microcirculation 7:183-192. 2000.
24. Kistler EB. Lefer AM. Hugli TE. Schmid-Schonbein GW: Plasma activation during splanchnic arterial occlusion shock. Shock 14:30-34. 2000.
25. Deitch EA. Shi HP. Lu Q. Feketeova E. Xu DZ: Serine proteases are involved in the pathogenesis of trauma-hemorrhage shock-induced gut and lung injury. Shock 19:452-456. 2003.
26. Cohen DB. Magnotti LJ. Lu Q. Xu DZ. Berezina TL. Zaets SB. Alvarez C. Machiedo G. Deitch EA: Pancreatic duct ligation reduces lung injury following trauma and hemorrhagic shock. Ann Surg 240:885-891. 2004.
27. Caputo FJ, Rupani B, Watkins AC, Barlos D, Vega D, Senthil M, Deiteh EA: Pancreatic duct ligation abrogates the trauma hemorrhage induced gut barrier failure and the subsequent production of biologically active intestinal lymph. Shock 28:441-446, 2007.
28. Majde JA: Animal models for hemorrhage and resuscitation research. J Trauma 54:S100-S105, 2003.
29. Turnbull IR, Wlzorek JJ, Osborne D, Hotchkiss RS, Coopersmith CM, Buchman TG: Effect of age on mortality and antibiotic efficiency in cecal ligation and puncture. Shock 19:310-313, 2003.
30. Angele MK, Schwacha MG, Ayala A, Chaudry IH: Effect of gender and sex hormones on immune responses following shock. Shock 14:81-90, 2000.
31. Holzheimer RG, Curley P, Saporoschetz IB, Doherty JM, Mannick JA, Rodrick ML: Orcadian rhythm of cytokine secretion following thermal injury in mice: implications for burn and trauma research. Shock 17:527-529, 2002.
32. Petrovsky N, Harrison LC: The chronobiology of human cytokine production. Intern Rev Immunol 16:635-649, 1998.
33. Kiank C, Koerner P, Kepler W, Traeger T, Maier S, Heidecke CD, Schuett C: Seasonal variations in inflammatory responses to sepsis and stress in mice. Cril Care Med 35:2352-2358, 2007.
34. Zorzet S, Perissin L, Rapozzi V, Giraldi T: Seasonal dependency of the effects of rotational stress and cyclophosphamide in mice bearing Lewis lung carcinoma. Brain Behav Immun 16:368-382, 2002.
35. Reis F, Hermida RC, Souza I, Maldonado J, Tavares P, Fontes-Ribeiro CA, Teixiera HM, Alcobia T, Almeida L, Teixiera F: Circadian and seasonal variations of endogenous ubiquinone plasma level. Chronobiol Int 19: 599-614, 2002.
36. Bartsch H, Bartsch C, Mecke D, Lippert TH: Seasonality of pineal melatonin production in the rat, possible synchronization by geomagnetic field. Chronobiol lnt 11:21-26, 1994.
37. Adams JC, Xu DZ, Lu Q, Deitch EA: Factors larger than 100 kD in posthemorrhagic shock mesenteric lymph are toxic for endothelial cells. Surgery 129:351-363, 2001.
38. Davidson MT, Deitch EA, Lu Q, Osband A, Feketeova E, Nemeth ZH, Hasko G, Xu DZ: A study of the biologic activity of trauma-hemorrhagic shock mesenteric lymph over time and the relative role of cytokines. Surgery 136:32-41, 2004.
39. Gonzalez RJ, Moore EE, Biffl WL, Ciesla DJ, Silliman CC: The lipid fraction of post-hemorrhagic shock mesenteric lymph (PHSML) inhibits neutrophil apoptosis and enhances cytotoxic potential. Shock 14:404-408, 2000.
40. Kaiser VL, Sifri ZC, dikdan GS, Berezina T, Zaets S, Lu Q, Xu DZ, Deiteh EA: Trauma-hemorrhagic shock mesenteric lymph from rat contains a modified form of albumin that is implicated in endothelial cell toxicity. Shock 23:417-425, 2005.
41. Cauwels A: Nitric oxide in shock. Kidney lnt 72:557-565, 2007.
42. López A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, et al.: Multiple-center randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32:21-30, 2004.
43. Alexander JH, Reynolds HR, Stebbins AL, Dzavik V, Harrington RA, Van de Werf F, Hochman JS: TRIUMPH Investigators: Effect of tilarginine acetate in patients with acute myocardial infarction and cariogenic shock. JAMA 297:1657-1666, 2007.